Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carducci

Showing results (171-180 of 386) with videos related to

Pageof 39
Sort By:
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Journal of Oncology Practice|May 12, 2016
Relationship Between Quality of Comorbid Condition Care and Costs for Cancer SurvivorsKevin D Frick, Claire F Snyder, Robert J Herbert, et al.
Journal of Viral Hepatitis|August 7, 2012
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patientsE Riva, C Scagnolari, K Monteleone, et al.
Plos One|September 6, 2007
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherinSushant K Kachhap, Dennis Faith, David Z Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Comparative pharmacokinetics of weekly and every-three-weeks docetaxelSharyn D Baker, Ming Zhao, Carlton K K Lee, et al.
Cancer Biology & Therapy|September 6, 2007
Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpointConnie Collins, Michael A Carducci, Mario A Eisenberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 27, 2010
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30Claire F Snyder, Amanda L Blackford, Julie R Brahmer, et al.
Cancer|January 6, 2017
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancerBrandon Bernard, Vinayak Muralidhar, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursWells A Messersmith, Michelle A Rudek, Sharyn D Baker, et al.
Pageof 39

Showing results (171-180 of 386) with videos related to

Sort By:
Pageof 39
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Journal of Oncology Practice|May 12, 2016
Relationship Between Quality of Comorbid Condition Care and Costs for Cancer SurvivorsKevin D Frick, Claire F Snyder, Robert J Herbert, et al.
Journal of Viral Hepatitis|August 7, 2012
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patientsE Riva, C Scagnolari, K Monteleone, et al.
Plos One|September 6, 2007
The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherinSushant K Kachhap, Dennis Faith, David Z Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Comparative pharmacokinetics of weekly and every-three-weeks docetaxelSharyn D Baker, Ming Zhao, Carlton K K Lee, et al.
Cancer Biology & Therapy|September 6, 2007
Preclinical and clinical studies with the multi-kinase inhibitor CEP-701 as treatment for prostate cancer demonstrate the inadequacy of PSA response as a primary endpointConnie Collins, Michael A Carducci, Mario A Eisenberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 27, 2010
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30Claire F Snyder, Amanda L Blackford, Julie R Brahmer, et al.
Cancer|January 6, 2017
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancerBrandon Bernard, Vinayak Muralidhar, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2006
Phase I study of continuous weekly dosing of dimethylamino benzoylphenylurea (BPU) in patients with solid tumoursWells A Messersmith, Michelle A Rudek, Sharyn D Baker, et al.
Pageof 39